21 – 35 of 35
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- « previous
- 1
- 2
- next »
- 2004
-
Mark
Matrix metalloproteinase-26 (Matrilysin-2) expression is high in endometrial hyperplasia and decreases with loss of histological differentiation in endometrial cancer.
(
- Contribution to journal › Article
-
Mark
Profily endometrialni exprese mRNA u vybranych matrix metaloproteinaz a tkanoveho inhibitoru metaloproteinaz-1
(
- Contribution to journal › Article
-
Mark
Nove matrix metaloproteinazy v cyklickem endometriu
(
- Contribution to journal › Article
-
Mark
Norepinephrine Transporter (NET), Serotonin Transporter (SERT), Vesicular Monoamine Transporter (VMAT2) and Organic Cation Transporters (OCT1, 2 and EMT) in Human Placenta from Pre-eclamptic and Normotensive Pregnancies.
(
- Contribution to journal › Article
-
Mark
Exprese MMP-26 v endometrialnich explantech pod vlivem estradiolu a progesteronu
(
- Contribution to journal › Article
- 2003
-
Mark
High preoperative plasma concentration of tissue plasminogen activator (tPA) is an independent marker for shorter overall survival in patients with ovarian cancer.
(
- Contribution to journal › Article
-
Mark
Epithelial expression of matrix metalloproteinase-26 is elevated at mid-cycle in the human endometrium
(
- Contribution to journal › Article
-
Mark
Plasma membrane and vesicular monoamine transporters in normal endometrium and early pregnancy decidua.
(
- Contribution to journal › Article
-
Mark
High tumor tissue concentration of urokinase plasminogen activator receptor is associated with good prognosis in patients with ovarian cancer
(
- Contribution to journal › Article
- 2002
-
Mark
High tumor tissue concentration of plasminogen activator inhibitor 2 (PAI-2) is an independent marker for shorter progression-free survival in patients with early stage endometrial cancer.
(
- Contribution to journal › Article
- 2001
-
Mark
Dedifferentiation of serous ovarian cancer from cystic to solid tumors is associated with increased expression of mRNA for urokinase plasminogen activator (uPA), its receptor (uPAR) and its inhibitor (PAI-1)
(
- Contribution to journal › Article
-
Mark
Urokinase plasminogen activator and its inhibitor, PAI-1, in association with progression-free survival in early stage endometrial cancer
(
- Contribution to journal › Article
-
Mark
Paracrine stimulation of capillary endothelial cell migration by endometrial tissue involves epidermal growth factor and is mediated via up-regulation of the urokinase plasminogen activator receptor
(
- Contribution to journal › Article
- 1998
-
Mark
High tissue content of urokinase plasminogen activator (u-PA) is associated with high stromal expression of u-PA mRNA in poorly differentiated serous ovarian carcinoma
(
- Contribution to journal › Article
- 1981
-
Mark
Proteinases and proteinase inhibitors in uterine fluid, with special reference to IUD-users
1981) In Acta obstetricia et gynecologica Scandinavica. Supplement, 0300-8835 ; 98(
- Thesis › Doctoral thesis (compilation)
- « previous
- 1
- 2
- next »